BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 7273018)

  • 1. Rescue of thymidine cytotoxicity in L1210 ascites by elevated endogenous levels of deoxycytidine.
    Egan EM; Sargent L; Rosowsky A; Kufe DW
    Cancer Treat Rep; 1981; 65(9-10):853-60. PubMed ID: 7273018
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thymidine arrest and synchrony of cellular growth in vivo.
    Kufe DW; Egan EM; Rosowsky A; Ensminger W; Frei E
    Cancer Treat Rep; 1980; 64(12):1307-17. PubMed ID: 7471121
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Threshold methotrexate concentration for in vivo inhibition of DNA synthesis in normal and tumorous target tissues.
    Chabner BA; Young RC
    J Clin Invest; 1973 Aug; 52(8):1804-11. PubMed ID: 4719662
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kinetic alterations induced by 5-fluorouracil in bone marrow, intestinal mucosa, and tumor.
    Myers CE; Young RC; Chabner BA
    Cancer Res; 1976 May; 36(5):1653-8. PubMed ID: 1268826
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reversal of methotrexate inhibition of colony growth of L1210 leukemia cells in semisolid medium.
    Nederbragt H; Uitendaal MP; van der Grint L; Leyva A; Pinedo HM
    Cancer Res; 1981 Mar; 41(3):1193-8. PubMed ID: 6970074
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improved therapeutic index with high-dose methotrexate: comparison of thymidine-purine rescue with citrovorum factor rescue in mice.
    Samuels LL; Straw JA
    Cancer Res; 1984 Jun; 44(6):2278-84. PubMed ID: 6609764
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of in vitro and in vivo effects of thymidine on L1210 leukemia in mice.
    Zaharko DS; Ramonas LM
    J Natl Cancer Inst; 1982 May; 68(5):875-80. PubMed ID: 6951095
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of deoxycytidine metabolism in vivo with high-dose thymidine in mice.
    Zaharko DS; Covey JM
    J Natl Cancer Inst; 1983 Nov; 71(5):1033-9. PubMed ID: 6580479
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased activation of 1-beta-D-arabinofuranosylcytosine by hydroxyurea in L1210 cells.
    Walsh CT; Craig RW; Agarwal RP
    Cancer Res; 1980 Sep; 40(9):3286-92. PubMed ID: 7427943
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of thymidine on the toxicity and antitumor activity of ftorafur.
    Grossie VB; Loo TL
    Cancer Treat Rep; 1981; 65(11-12):1087-91. PubMed ID: 6794908
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synergistic action of 5-aza-2'-deoxycytidine and 3-deazauridine on L1210 leukemic cells and EMT6 tumor cells.
    Momparler RL; VeselĂ˝ J; Momparler LF; Rivard GE
    Cancer Res; 1979 Oct; 39(10):3822-7. PubMed ID: 476619
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative study of deoxycytidine incorporation in large and small lymphocytes of the mouse.
    Hamatani K; Kawahara A; Amano M
    Cell Tissue Kinet; 1983 Nov; 16(6):557-70. PubMed ID: 6605195
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biochemical effects and therapeutic potential of tunicamycin in murine L1210 leukemia.
    Morin MJ; Bernacki RJ
    Cancer Res; 1983 Apr; 43(4):1669-74. PubMed ID: 6339042
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhancement of 1-beta-D-arabinofuranosylcytosine accumulation within L1210 cells and increased cytotoxicity following thymidine exposure.
    Grant S; Lehman C; Cadman E
    Cancer Res; 1980 May; 40(5):1525-31. PubMed ID: 7370990
    [No Abstract]   [Full Text] [Related]  

  • 15. Cytokinetic comparison of thymidine and leucovorin rescue of marrow in humans after exposure to high-dose methotrexate.
    Howell SB; Krishan A; Frei E
    Cancer Res; 1979 Apr; 39(4):1315-20. PubMed ID: 311245
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blood thymidine level and iododeoxyuridine incorporation and reutilization in DNA in mice given long-acting thymidine pellets.
    Lee DJ; Prensky W; Krause G; Hughes WL
    Cancer Res; 1976 Dec; 36(12):4577-83. PubMed ID: 1000502
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors modifying the synergistic toxicity of deoxycytidine in combination with thymidine plus 5-fluorouracil in HeLa cells.
    Fried J; Perez AG; Doblin JM; Clarkson BD
    Cell Tissue Kinet; 1983 Nov; 16(6):539-48. PubMed ID: 6627345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Levodopa and dopamine analogs: dihydroxy and trihydroxybenzylamines as novel quinol antitumor agents in experimental leukemia in vivo.
    Wick MM
    Cancer Treat Rep; 1981; 65(9-10):861-7. PubMed ID: 7273019
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of uridine rescue to enhance the antitumor selectivity of 5-fluorouracil.
    Klubes P; Cerna I
    Cancer Res; 1983 Jul; 43(7):3182-6. PubMed ID: 6850628
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of 5-fluorouracil metabolism by thymidine. In vivo and in vitro studies on RNA-directed effects in rat liver and hepatoma.
    Engelbrecht C; Ljungquist I; Lewan L; Yngner T
    Biochem Pharmacol; 1984 Mar; 33(5):745-50. PubMed ID: 6201174
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.